% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Janssen:163604,
author = {Janssen, Olin and Jansen, Willemijn J and Vos, Stephanie J
B and Boada, Merce and Parnetti, Lucilla and Gabryelewicz,
Tomasz and Fladby, Tormod and Molinuevo, José Luis and
Villeneuve, Sylvia and Hort, Jakub and Epelbaum, Stéphane
and Lleó, Alberto and Engelborghs, Sebastiaan and van der
Flier, Wiesje M and Landau, Susan and Popp, Julius and
Wallin, Anders and Scheltens, Philip and Rikkert, Marcel
Olde and Snyder, Peter J and Rowe, Chris and Chételat,
Gaël and Ruíz, Agustin and Marquié, Marta and Chipi,
Elena and Wolfsgruber, Steffen and Heneka, Michael and
Boecker, Henning and Peters, Oliver and Jarholm, Jonas and
Rami, Lorena and Tort-Merino, Adrià and Binette, Alexa
Pichet and Poirier, Judes and Rosa-Neto, Pedro and Cerman,
Jiri and Dubois, Bruno and Teichmann, Marc and Alcolea,
Daniel and Fortea, Juan and Sánchez-Saudinós, M Belén and
Ebenau, Jarith and Pocnet, Cornelia and Eckerström, Marie
and Thompson, Louisa and Villemagne, Victor and Buckley,
Rachel and Burnham, Samantha and Delarue, Marion and
Freund-Levi, Yvonne and Wallin, Åsa K and Ramakers, Inez
and Tsolaki, Magda and Soininen, Hilkka and Hampel, Harald
and Spiru, Luiza and Tijms, Betty and Ossenkoppele, Rik and
Verhey, Frans R J and Jessen, Frank and Visser, Pieter
Jelle},
collaboration = {Initiative, Alzheimer's Disease Neuroimaging and group,
FACEHBI study and group, PREVENT-AD research},
title = {{C}haracteristics of subjective cognitive decline
associated with amyloid positivity.},
journal = {Alzheimer's and dementia},
volume = {18},
number = {10},
issn = {1552-5260},
address = {Hoboken, NJ},
publisher = {Wiley},
reportid = {DZNE-2022-00350},
pages = {1832-1845},
year = {2022},
note = {(CC BY-NC)},
abstract = {The evidence for characteristics of persons with subjective
cognitive decline (SCD) associated with amyloid positivity
is limited.In 1640 persons with SCD from 20 Amyloid
Biomarker Study cohort, we investigated the associations of
SCD-specific characteristics (informant confirmation,
domain-specific complaints, concerns, feelings of worse
performance) demographics, setting, apolipoprotein E gene
(APOE) ε4 carriership, and neuropsychiatric symptoms with
amyloid positivity.Between cohorts, amyloid positivity in
70-year-olds varied from $10\%$ to $76\%.$ Only older age,
clinical setting, and APOE ε4 carriership showed univariate
associations with increased amyloid positivity. After
adjusting for these, lower education was also associated
with increased amyloid positivity. Only within a research
setting, informant-confirmed complaints, memory complaints,
attention/concentration complaints, and no depressive
symptoms were associated with increased amyloid positivity.
Feelings of worse performance were associated with less
amyloid positivity at younger ages and more at older
ages.Next to age, setting, and APOE ε4 carriership,
SCD-specific characteristics may facilitate the
identification of amyloid-positive individuals.},
keywords = {Humans / Amyloid / Amyloidogenic Proteins / Amyloidosis /
Apolipoprotein E4: genetics / Biomarkers / Brain: metabolism
/ Cognitive Dysfunction: genetics / Cognitive Dysfunction:
psychology / Positron-Emission Tomography / Alzheimer's
disease (Other) / amyloid (Other) / cerebrospinal fluid
(Other) / positron emission tomography (Other) / subjective
cognitive decline (Other)},
cin = {AG Wagner / AG Jessen / Delcode},
ddc = {610},
cid = {I:(DE-2719)1011201 / I:(DE-2719)1011102 /
I:(DE-2719)5000034},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
experiment = {EXP:(DE-2719)DELCODE-20140101},
typ = {PUB:(DE-HGF)16},
pmc = {pmc:PMC9786747},
pubmed = {pmid:34877782},
doi = {10.1002/alz.12512},
url = {https://pub.dzne.de/record/163604},
}